Tofacitinib: a new oral Janus kinase inhibitor for psoriasis

被引:1
|
作者
Gimenez-Arnau, A. M. [1 ]
机构
[1] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, IMIM, Barcelona, Spain
关键词
HERPES-ZOSTER; EFFICACY; MODERATE; VACCINE;
D O I
10.1111/bjd.17323
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:13 / 14
页数:2
相关论文
共 50 条
  • [31] Cardiovascular Safety Findings In Rheumatoid Arthritis Patients Treated With Tofacitinib, A Novel, Oral Janus Kinase Inhibitor
    Charles-Schoeman, C.
    Wicker, P.
    Gonzalez-Gay, M. A.
    Wood, S. P.
    Boy, M. G.
    Geier, J.
    Gruben, D.
    Soma, K.
    Riese, R.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S191 - S191
  • [32] REESTABLISHMENT OF EFFICACY OF TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN RHEUMATOID ARTHRITIS PATIENTS AFTER TEMPORARY DISCONTINUATION
    Kaine, J.
    Tesser, J.
    DeMasi, R.
    Takiya, L.
    Wang, L.
    Snyder, M.
    Fan, H.
    Wollenhaupt, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 275 - 276
  • [33] JAAD Game Changers: Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
    Grant-Kels, Jane M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2024, 91 (05) : 1028 - 1028
  • [34] Tofacitinib, an Oral Janus Kinase Inhibitor: Pooled Efficacy and Safety Analyses in an Australian Rheumatoid Arthritis Population
    Stephen Hall
    Peter Nash
    Maureen Rischmueller
    David Bossingham
    Paul Bird
    Nicola Cook
    David Witcombe
    Koshika Soma
    Kenneth Kwok
    Krishan Thirunavukkarasu
    Rheumatology and Therapy, 2018, 5 : 383 - 401
  • [35] Tofacitinib, an oral Janus kinase inhibitor: analysis of malignancies across the rheumatoid arthritis clinical development programme
    Curtis, Jeffrey R.
    Lee, Eun Bong
    Kaplan, Irina V.
    Kwok, Kenneth
    Geier, Jamie
    Benda, Birgitta
    Soma, Koshika
    Wang, Lisy
    Riese, Richard
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 (05) : 831 - 841
  • [36] Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials
    Papp, K. A.
    Menter, M. A.
    Abe, M.
    Elewski, B.
    Feldman, S. R.
    Gottlieb, A. B.
    Langley, R.
    Luger, T.
    Thaci, D.
    Buonanno, M.
    Gupta, P.
    Proulx, J.
    Lan, S.
    Wolk, R.
    BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (04) : 949 - 961
  • [37] TOFACITINIB, AN ORAL JANUS KINASE INHIBITOR, IN THE TREATMENT OF RHEUMATOID ARTHRITIS - THE RESULTS OF RUSSIAN NATIONAL REGISTER OF PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH TOFACITINIB
    Gaydukova, Inna
    Mazurov, V.
    Zhilyaev, Evgeniy
    Grabovetskaya, Iuliia
    Marusenko, Irina
    Vasilenko, Elizaveta
    Abdulganieva, Diana
    Smitienko, Ilia
    Misiyuk, Anna
    Lukina, Galina
    Knyazeva, Larisa
    Kalinina, Elena
    Samigullina, Ruzana
    Bondareva, Irina
    Yudina, Natalya
    Lapkina, N.
    Nasonov, Evgeny
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 359 - 360
  • [38] The Pharmacokinetics, Metabolism, and Clearance Mechanisms of Tofacitinib, a Janus Kinase Inhibitor, in Humans
    Dowty, Martin E.
    Lin, Jinyan
    Ryder, Tim F.
    Wang, Weiwei
    Walker, Gregory S.
    Vaz, Alfin
    Chan, Gary L.
    Krishnaswami, Sriram
    Prakash, Chandra
    DRUG METABOLISM AND DISPOSITION, 2014, 42 (04) : 759 - 773
  • [39] Concurrent bullous pemphigoid and psoriasis vulgaris successfully treated with Janus kinase inhibitor tofacitinib: A case report and review of the literature
    Li, Hongda
    Wang, Honglei
    Qiao, Guizhi
    Liu, Yongxia
    Zhang, Furen
    Pan, Futang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [40] Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
    Berbert Ferreira, Sineida
    Berbert Ferreira, Rachel
    Neves Neto, Afonso Cesar
    Assef, Silvana Martins Caparroz
    Scheinberg, Morton
    CASE REPORTS IN DERMATOLOGY, 2021, 13 (01): : 190 - 194